Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy.
Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy.
复制标题
DOI：
10.2217/clp.12.33
复制
发表时间：
2012-06
影响因子：
--
通讯作者：
Kerwin WS
中科院分区：
文献类型：
--
作者：
Zhao XQ;Kerwin WS
Lipid abnormalities play important roles in the development of atherosclerosis. Lipid therapies result in alterations in atherosclerotic plaques including halting of progression of the plaque, lipid transport out of the plaque and reducing inflammatory activity, which lead to plaque morphologies that are less prone to disruption, the main cause of clinical events. In order to investigate and monitor plaque morphological changes during lipid therapy in vivo we need an imaging method that can provide accurate assessment of plaque tissue components and activity. MRI of atherosclerosis has been validated as a reliable assessment of the size of the vessel lumen, but also the size of the plaque, its tissue composition and plaque activity, including inflammation. The purpose of this review is to summarize the state of evidence for the direct assessment of atherosclerotic plaque and its change by MRI, and to establish the proven role of MRI of atherosclerosis in pharmaceutical trials with lipid therapy.
